Functionalized beta-sheet peptide stabilized membrane proteins, constructs comprising same, and methods of forming and using same

US9821278B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9821278-B2
Application numberUS-201515506654-A
CountryUS
Kind codeB2
Filing dateAug 25, 2015
Priority dateAug 25, 2014
Publication dateNov 21, 2017
Grant dateNov 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Constructs having membrane proteins stabilized by functionalized beta-sheet peptides are provided. The constructs can be associated with or covalently linked to supports. The support can be a membrane. The membrane can be used to selectively move desired particles from one side of the membrane to the other while impeding passage of undesired particles through the membrane. Methods of making and using such constructs and membranes are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A membrane configured for selectively passing desired particles across the membrane comprising: a support; and a plurality of membrane protein molecules associated with the support, each one of the membrane protein molecules being stabilized by a plurality of functionalized β-sheet peptides, each one of the functionalized β-sheet peptides comprising at least one functional group, the functionalized β-sheet peptides being linked to the support via at least one of the at least one functional groups, wherein the functionalized β-sheet peptides comprise at least eight alternating polar and apolar amino acid residues with a hydrophobic moiety at each end and do not comprise a hydrophobin; and wherein the at least one functional group comprises an azide, an alkyne, an alkene, a vinyl, an azidophenyl, a thiol, a cyclopropyl, or an amido group, or wherein the at least one functional group is provided by a bifunctional crosslinker. 2. The membrane as defined in claim 1 , wherein at least some of the functionalized β-sheet peptides are covalently linked to the support. 3. The membrane as defined in claim 1 , wherein the membrane protein molecules are selected from group consisting of aquaporin, ChIEF, F 0 F 1 -ATPase, OmpG, NaChBAc, bacteriorhodopsin, alamethicin, hemolysin, NADH reductase, OmpF, RC (photosynthetic reaction centre), NtAPQ1, NtPIP2:1, AQP0, AQP10, SoPIP2, TsX, gramicidin A, MloK1, LamB, FhuA, ATPase, hemagglutinin, cytochrome C oxidase, polymyxin B, cecropinA and proteorhodopsin. 4. The membrane as defined claim 1 , wherein the membrane protein molecules form a plurality of channels in the membrane to selectively permit passage of the desired particles therethrough. 5. The membrane as defined in claim 1 , wherein the membrane protein molecules are stabilized by the functionalized β-sheet peptides to allow the membrane protein molecules to selectively transport the desired particles across the membrane. 6. The membrane as defined in claim 1 , wherein the support is a matrix for immobilizing the complex comprising the membrane protein molecules stabilized by the functionalized β-sheet peptides. 7. The membrane as defined in claim 1 , wherein the membrane protein molecules comprise aquaporin and the desired particles comprise water molecules. 8. The membrane as defined in claim 1 , wherein: the membrane protein molecules comprise ChIEF and the desired particles comprise protons, sodium ions, or calcium ions; or the membrane protein molecules comprise F 0 F 1 -ATPase and the desired particles comprise ATP or protons; or the membrane protein molecules comprise OmpG and the desired particles comprise disaccharides; or the membrane protein molecules comprise NaChBAc and the desired particles comprise sodium ions; or the membrane protein molecules comprise alpha-hemolysin, MspA ( Mycobacterium smegmatis porin A), OmpF or OmpG and the desired particles comprise polynucleotides; or the membrane protein molecules comprise alamethicin, hemolysin, NADH reductase, OmpG, OmpF or photosynthetic reaction centre and the desired particles comprise electrons; or the membrane protein molecules comprise alamethicin and the desired particles comprise calcium or calcein; or the membrane protein comprises NtAPQ1 or NtPIP2:1 and the desired particles comprise carbon dioxide; or the membrane protein comprises AQP0, AQP10 or SoPIP2; 1 and the desired particles comprise water; or the membrane protein comprises TsX and the desired particles comprise nucleosides; or the membrane protein comprises OmpF and the desired particles comprise acridine orange, paraquat, pyocyanin, actylthiocholine, enone, ELF97, 7-ADCA, PGME, nucleosides, ampicillin, L-ascorbic acid, CO, Na 2 S 2 O 4 , or ONOO − ; or the membrane protein comprises gramicidin A and the desired particles comprise monovalent cations; or the membrane protein comprises LamB and the desired particles comprise sugars or DNA; or the membrane protein comprises FhuA and the desired particles comprise sulphorhodamine B, 3,3′,5,5′-tetramethylbenzidine, NAD, DNA, or calcein; or the membrane protein comprises bacteriorhodopsin, proteorhodopsin, or both bacteriorhodopsin and cytochrome C oxidase and the desired particles comprise H + ; or the membrane protein comprises both bacteriorhodopsin and ATPase and the desired particles comprise H + and electrons; or the membrane protein comprises cytochrome C oxidase and the desired particles comprise electrons; or the membrane protein comprises cecropinA, polymyxin B, or hemolysin and the desired particles comprise calcein. 9. The membrane as defined in claim 1 , wherein the support comprises a polymer, carbon nanotube mesh, or nanocrystalline cellulose, and wherein the polymer comprises polysulfone, polycarbonate, or polylactone. 10. The membrane as defined in claim 1 , wherein the membrane protein comprises aquaporin, and wherein the membrane is configured to impede passage of sodium ions, chloride ions, ammonia, urea, dye, pesticides, pharmaceutical waste, and other organic compounds while selectively permitting passage of water through the membrane. 11. A complex comprising a membrane protein stabilized by a plurality of functionalized β-sheet peptides, each one of the functionalized β-sheet peptides comprising at least one functional group, wherein the β-sheet peptides comprise at least eight alternating polar and apolar amino acid residues with a hydrophobic moiety at each end and do not comprise a hydrophobin; and wherein the at least one functional group comprises an azide, an alkyne, an alkene, a vinyl, an azidophenyl, a thiol, a cyclopropyl, or an amido group, or wherein the at least one functional group is provided by a bifunctional crosslinker. 12. The complex as defined in claim 11 , wherein the complex is immobilized on a solid support by conjugation of at least one of the at least one functional groups on at least one of the plurality of functionalized β-sheet peptides to the solid support. 13. The membrane as defined in claim 1 , wherein the functionalized β-sheet peptides comprise the amino acid sequence of SEQ ID NO:1, wherein optionally one or more amino acids comprises an N-methyl amino acid. 14. The membrane as defined in claim 1 , wherein the functional group on the functionalized β-sheet peptides comprises an azide, an alkyne, an alkene, a vinyl, an azidophenyl, or a thiol. 15. The membrane as defined in claim 1 , wherein the functionalized β-sheet peptides comprise the structure (I), (II), (III), (IV), (V) or (VI): wherein R 4 and R 5 are independently an azide group, alkyne group, alkene group, thio group, azidophenyl group, or vinyl group. 16. The membrane as defined in claim 1 , wherein the at least one functional group of the functionalized β-sheet peptides is provided by the bifunctional crosslinker, and wherein the bifunctional crosslinker comprises a photo-reactive functional group. 17. The membrane as defined

Assignees

Inventors

Classifications

  • C02F1/44Primary

    by dialysis, osmosis or reverse osmosis {(general membrane separation processes B01D61/00, membrane modules B01D63/00, electrodialysis C02F1/4693, combination of membrane modules and bioreactors C02F3/1268)} · CPC title

  • Polyethersulfones · CPC title

  • B01D71/82Primary

    characterised by the presence of specified groups, e.g. introduced by chemical after-treatment · CPC title

  • Dyes; Colorants; Fluorescent agents · CPC title

  • Pesticides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9821278B2 cover?
Constructs having membrane proteins stabilized by functionalized beta-sheet peptides are provided. The constructs can be associated with or covalently linked to supports. The support can be a membrane. The membrane can be used to selectively move desired particles from one side of the membrane to the other while impeding passage of undesired particles through the membrane. Methods of making and…
Who is the assignee on this patent?
Univ Alberta
What technology area does this patent fall under?
Primary CPC classification C02F1/44. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).